Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease

This publication has 44 references indexed in Scilit:

• N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS
  European Heart Journal, 2012
• Elevated B-Type Natriuretic Peptide Is Associated With Increased In-Hospital Mortality or Cardiac Arrest in Patients Undergoing Implantable Cardioverter-Defibrillator Implantation
  Circulation: Cardiovascular Quality and Outcomes, 2011
• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
  The Lancet, 2010
• Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
  JACC, 2008
• Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
  The Lancet, 2008
• Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure
  Circulation, 2007
• B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes
  Heart, 2005
• Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
  New England Journal of Medicine, 2004
• B Type natriuretic peptide: a good omen in myocardial ischaemia?
  Heart, 2003
• Increased cardiac BNP expression associated with myocardial ischemia
  The FASEB Journal, 2003